Evidence map›Paper›PMID 42816495›Full record

ArticleNature communications2026

A dual-host regulatory hub integrating biofilm formation and innate immunity resistance.

Alexandre Baillez, Amélie Dewitte, François Pierre, Mounia Kortebi, Virginia S Lioy, Mélanie Hillion, Julie Hardouin, Sébastien Janel, Xavier Thuru, Charlotte Clarisse and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alexandre BaillezUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Amélie Dewitte *Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
François Pierre *Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Mounia KortebiUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), F-91198 Gif-sur-Yvette, France.
Virginia S LioyUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), F-91198 Gif-sur-Yvette, France.ORCID 0000-0002-5366-0462
Mélanie HillionUniversité Rouen Normandie, INSA Rouen Normandie, CNRS, Laboratoire Polymères, Biopolymères, Surfaces UMR-6270, F-76000 Rouen, France.ORCID 0000-0003-2973-6153
Julie HardouinUniversité Rouen Normandie, INSA Rouen Normandie, CNRS, Laboratoire Polymères, Biopolymères, Surfaces UMR-6270, F-76000 Rouen, France.ORCID 0000-0003-4588-9811
Sébastien JanelUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0001-6736-3162
Xavier ThuruUniv. Lille, Inserm, CHU Lille, CNRS, U1366-UMR9020 - CRCLille - Cancer Research Center of Lille, F-59000 Lille, France.
Charlotte ClarisseUniv. Lille, Inserm, CHU Lille, CNRS, U1366-UMR9020 - CRCLille - Cancer Research Center of Lille, F-59000 Lille, France.
Hassiba BouafiaUniv. Lille, Inserm, CHU Lille, CNRS, U1366-UMR9020 - CRCLille - Cancer Research Center of Lille, F-59000 Lille, France.ORCID 0009-0003-0909-8585
Catherine Robbe MasselotUniv. Lille, CNRS, UMR8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
Sébastien Bontemps-GalloUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Florent SebbaneUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. florent.sebbane@inserm.fr.ORCID 0000-0003-3811-9691

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-11-IDEX-0003Agence Nationale de la Recherche (French National Research Agency) ANR-20-CE35-005Agence Nationale de la Recherche (French National Research Agency) ANR-21-CE15-0047EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101118880
6 · The paper itself

Abstract

Vector-borne pathogens must adapt to sharply distinct host environments, yet the regulatory logic that coordinates transitions between opposing host-specific programs remains poorly defined. Here, we identify a minimal regulatory module in the flea-borne pathogen Yersinia pestis that integrates vector transmission with resistance to mammalian innate immunity. Screening of flea-induced genes uncovered the regulator HdfR, which acts primarily through activation of maoP, encoding a nucleoid-associated protein. This HdfR-MaoP module promotes biofilm-dependent foregut blockage in the flea while coordinating baseline envelope adaptations that limit complement recognition and inducible responses that confer resistance to antimicrobial peptides under mammalian host-like conditions. Functional interchangeability of HdfR and MaoP homologs reveals evolutionary conservation of this regulatory logic, and pharmacological perturbation of the module sensitizes Y. pestis to antimicrobial peptides. Together, these findings define a parsimonious and evolutionarily conserved regulatory hub that orchestrates bacterial success across abrupt environmental transitions and exposes a tractable point of intervention.

Indexed as

BiofilmsHost-Pathogen InteractionsImmunity, InnateSiphonapteraYersinia pestisAnimalsAntimicrobial PeptidesAntimicrobial Peptides

Identifiers

PMID42816495
PMCPMC13627719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.